Armata Pharmaceuticals (ARMP) Current Assets (2016 - 2018)
Historic Current Assets for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $5.1 million.
- Armata Pharmaceuticals' Current Assets fell 3598.7% to $5.1 million in Q3 2018 from the same period last year, while for Sep 2018 it was $5.1 million, marking a year-over-year decrease of 3598.7%. This contributed to the annual value of $5.4 million for FY2017, which is 1469.98% down from last year.
- According to the latest figures from Q3 2018, Armata Pharmaceuticals' Current Assets is $5.1 million, which was down 3598.7% from $6.1 million recorded in Q2 2018.
- Over the past 5 years, Armata Pharmaceuticals' Current Assets peaked at $17.0 million during Q1 2015, and registered a low of $2.6 million during Q1 2017.
- Its 5-year average for Current Assets is $9.1 million, with a median of $8.0 million in 2017.
- As far as peak fluctuations go, Armata Pharmaceuticals' Current Assets crashed by 6602.13% in 2014, and later skyrocketed by 24152.34% in 2018.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Current Assets stood at $7.0 million in 2014, then surged by 42.68% to $10.0 million in 2015, then tumbled by 36.97% to $6.3 million in 2016, then fell by 14.7% to $5.4 million in 2017, then fell by 5.03% to $5.1 million in 2018.
- Its Current Assets was $5.1 million in Q3 2018, compared to $6.1 million in Q2 2018 and $8.7 million in Q1 2018.